Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
4.590
+0.100 (2.23%)
At close: Aug 14, 2026, 4:00 PM EDT
4.570
-0.020 (-0.44%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Emergent BioSolutions Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Emergent BioSolutions stock has a consensus rating of "Strong Buy" and an average price target of $11. The average 1-year stock price forecast is 139.65% higher than the current stock price, while the lowest is $10 (+117.86%) and the highest is $12 (+161.44%).
Price Target: $11 (+139.65%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Emergent BioSolutions stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 → $10 | Buy | Reiterates | $12 → $10 | +117.86% | Aug 10, 2026 |
Financial Forecast
Revenue This Year
655.70M
from 742.90M
Decreased by -11.74%
Revenue Next Year
810.00M
from 655.70M
Increased by 23.53%
EPS This Year
0.36
from 1.53
Decreased by -76.47%
EPS Next Year
-0.96
from 0.36
EPS and Forward PE are based on non-GAAP adjusted numbers.